Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKinsey
AstraZeneca
Chubb
Teva
Johnson and Johnson
Julphar
Cantor Fitzgerald
Queensland Health

Generated: May 23, 2018

DrugPatentWatch Database Preview

SODIUM THIOSULFATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Sodium Thiosulfate patents expire, and when can generic versions of Sodium Thiosulfate launch?

Sodium Thiosulfate is a drug marketed by Us Army and Hope Pharms and is included in two NDAs. There are three patents protecting this drug.

This drug has fifteen patent family members in eight countries.

The generic ingredient in SODIUM THIOSULFATE is sodium thiosulfate. There are one thousand four hundred and twenty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium thiosulfate profile page.
Summary for SODIUM THIOSULFATE
Drug patent expirations by year for SODIUM THIOSULFATE
Synonyms for SODIUM THIOSULFATE
10102-17-7 (pentahydrate)
1374442-73-5
13773-27-8
220945-47-1
7772-98-7
AC1L2NGO
AC1Q1USN
ACMC-1BLMJ
AI3-01237
AKHNMLFCWUSKQB-UHFFFAOYSA-L
AKOS015856704
AKOS016372312
anhydrous sodium thiosulfate
BP-21059
CHEBI:132112
CHEMBL3753202
Chlorine Control
Chlorine Cure
CTK2H7219
D0P9NT
Declor-It
Detoxol
disodium sulfurothioate
Disodium thiosulfate
DTXSID9042417
EC 231-867-5
EINECS 231-867-5
FT-0696570
HSDB 592
Hypo
Hypo (VAN)
Hypo alcohol
Hypo alcohol, in ethanol
Hyposulphite of soda
I14-16584
KS-00000VC8
KSC377E1T
L0IYT1O31N
LS-153406
LT03329071
MFCD00003499
MolPort-003-926-155
MolPort-006-118-733
Na2O3S2
Na2S2O3
NSC 45624
RP22166
RTR-031296
SC-74795
Sodium oxide sulfide
Sodium oxide sulfide (Na2S2O3)
sodium thio-sulfate
sodium thiosulfat
sodium thiosulfate (anhydrous)
Sodium thiosulfate (Na2S2O3)
Sodium thiosulfate 2.5M solution
Sodium thiosulfate anhydrous
Sodium thiosulfate concentrate
Sodium thiosulfate solution, 0.01 M
Sodium thiosulfate solution, 0.025 M
Sodium thiosulfate solution, 0.1 M
Sodium thiosulfate solution, 1 M
Sodium thiosulfate solution, 2 g/dL in deionized water
Sodium thiosulfate solution, Silver stain kit component, 0.5 % (w/v) sodium thiosulfate in H2O
Sodium thiosulfate, >=99.99% trace metals basis
Sodium thiosulfate, anhydrous
Sodium thiosulfate, anhydrous, >=98% (calc. to the dried substance)
Sodium thiosulfate, AR, >=98%
Sodium thiosulfate, LR, >=97%
Sodium thiosulfate, p.a., 98.0%
Sodium thiosulfate, purum p.a., anhydrous, >=98.0% (RT)
Sodium thiosulfate, ReagentPlus(R), 99%
Sodium thiosulfate, SAJ first grade, >=90.0%
Sodium thiosulfate, Vetec(TM) reagent grade, 99%
Sodium thiosulfate,anhydrous
Sodium thiosulphate
Sodium thiosulphate (Na2S2O3)
sodiumthiosulfate
Thiosulfuric acid (H2S2O3) disodium salt
Thiosulfuric acid (H2S2O3), disodium salt
Thiosulfuric acid (H2S2O3), sodium salt (1:2)
Thiosulfuric acid, disodium salt
TR-031296
TRA0058020
UNII-L0IYT1O31N
X5843

US Patents and Regulatory Information for SODIUM THIOSULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Army SODIUM THIOSULFATE sodium thiosulfate INJECTABLE;INJECTION 020166-001 Feb 14, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hope Pharms SODIUM THIOSULFATE sodium thiosulfate SOLUTION;INTRAVENOUS 203923-001 Feb 14, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Hope Pharms SODIUM THIOSULFATE sodium thiosulfate SOLUTION;INTRAVENOUS 203923-001 Feb 14, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Hope Pharms SODIUM THIOSULFATE sodium thiosulfate SOLUTION;INTRAVENOUS 203923-001 Feb 14, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Non-Orange Book US Patents for SODIUM THIOSULFATE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,579,345 Sodium thiosulfate-containing pharmaceutical compositions ➤ Try a Free Trial
8,715,746 Sodium thiosulfate-containing pharmaceutical compositions ➤ Try a Free Trial
9,144,580 Sodium thiosulfate-containing pharmaceutical compositions ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Supplementary Protection Certificates for SODIUM THIOSULFATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90062-5 Sweden ➤ Try a Free Trial PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
90064-1 Sweden ➤ Try a Free Trial PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
C0022 France ➤ Try a Free Trial PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825
C/GB02/042 United Kingdom ➤ Try a Free Trial PRODUCT NAME: ERTAPENEM ((1R,5S,6S,8R,2'S,4'S)-2-(2-(3-CARBOXYPHENYLCARBAMOYL)PYRROLIDIN-4-YLTHIO)-6-(1-HYDROXYETHYL)-1-METHYLCARBAPENEM-3-CARBOXYLIC ACID), A PHARMACEUTICALLY ACCEPTABLE SALT OR IN VIVO HYDROLYSABLE ESTER THEREOF, ESPECIALLY AS THE MONOSODIUM SALT ERTA; REGISTERED: UK EU/1/02/216/001 20020422
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Express Scripts
QuintilesIMS
Citi
Farmers Insurance
Chinese Patent Office
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.